Cue Biopharma Inc
NASDAQ:CUE
Cue Biopharma Inc
NASDAQ:CUE
Price:
35.73
USD
5.15%
Market Closed
Market Cap:
$56.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cue Biopharma Inc
NASDAQ:CUE
|
US |
|
L
|
Lam Research Corp
SWB:LAR
|
US |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BBVA
|
ES |
|
H
|
Hess Corp
XMUN:AHC
|
US |
Wall St Price Targets
CUE Price Targets Summary
Cue Biopharma Inc
Cue Biopharma Inc
Wall Street analysts forecast CUE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CUE is 122.4 USD with a low forecast of 121.2 USD and a high forecast of 126 USD.
Lowest Forecast
Price Target
121.2
USD
239% Upside
Average Forecast
Price Target
122.4
USD
243% Upside
Highest Forecast
Price Target
126
USD
253% Upside
Cue Biopharma Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CUE's stock price target?
Price Target
122.4
USD
122.4
USD
According to Wall Street analysts, the average 1-year price target for CUE is 122.4 USD with a low forecast of 121.2 USD and a high forecast of 126 USD.
What is the Revenue forecast for Cue Biopharma Inc?
Projected CAGR
17%
17%
The compound annual growth rate for Revenue over the next 8 years is 17%.
